$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adhera Therapeutics, Inc.. Get notifications about new insider transactions in Adhera Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 05 2019 | ATRX | Adhera Therapeutic ... | Stanley Rhonda L. | SVP Finance & Accou ... | Option Exercise | A | 0.09 | 350,000 | 31,500 | 350,000 | |
| Apr 04 2019 | MRNA | Adhera Therapeutic ... | Phelan Nancy R. | CEO and Secretary | Option Exercise | A | 0.37 | 1,500,000 | 555,000 | 1,500,000 | |
| Jan 17 2019 | MRNA | Adhera Therapeutic ... | Teague Robert Eric | Chief Financial Off ... | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
| Oct 04 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Director | Sell | D | 0.50 | 500,000 | 250,000 | 612,716 | 1.1 M to 612.7 K (-44.94 %) |
| Sep 26 2018 | MRNA | Marina Biotech, In ... | Teague Robert Eric | Chief Financial Off ... | Option Exercise | A | 0.55 | 450,000 | 247,500 | 450,000 | |
| Jul 16 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | P | 0.55 | 300,000 | 165,000 | 300,000 | |
| Jul 16 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | P | 0.50 | 40 | 20 | 40 | |
| Jul 12 2018 | MRNA | Marina Biotech, In ... | Emerson Erik | Chief Commercial Of ... | Option Exercise | A | 0.66 | 1,125,000 | 742,500 | 1,125,000 | |
| Jul 11 2018 | MRNA | Marina Biotech, In ... | Hacksell Uli | Director | Option Exercise | A | 0.66 | 1,000,000 | 660,000 | 1,000,000 | |
| Jul 11 2018 | MRNA | Marina Biotech, In ... | Moscato Robert Jr. | Chief Executive Off ... | Option Exercise | A | 0.66 | 1,500,000 | 990,000 | 1,500,000 | |
| May 04 2018 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Option Exercise | A | 0.98 | 100,000 | 98,000 | 100,000 | ||
| May 04 2018 | MRNA | Marina Biotech, In ... | Calais Philippe | Option Exercise | A | 0.98 | 80,000 | 78,400 | 80,000 | ||
| May 04 2018 | MRNA | Marina Biotech, In ... | Ranker Philip C | Option Exercise | A | 0.98 | 200,000 | 196,000 | 200,000 | ||
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | P | 0.55 | 2,564,465 | 1,410,456 | 2,564,465 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | P | 0.50 | 163 | 82 | 163 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.55 | 142,500 | 78,375 | 142,500 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.50 | 19 | 10 | 19 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.55 | 859,725 | 472,849 | 859,725 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.50 | 115 | 58 | 115 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.55 | 258,825 | 142,354 | 258,825 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | C | 0.50 | 35 | 18 | 35 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | A | 0.55 | 16,875 | 9,281 | 16,875 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Trieu Vuong | Executive Chairman | Option Exercise | A | 0.50 | 2 | 1 | 2 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Hwang Larn | Chief Scientific Of ... | Option Exercise | C | 0.55 | 78,300 | 43,065 | 78,300 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Hwang Larn | Chief Scientific Of ... | Option Exercise | C | 0.50 | 10 | 5 | 10 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.55 | 135,000 | 74,250 | 135,000 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.50 | 18 | 9 | 18 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | BLECH ISAAC | Director | Option Exercise | C | 0.55 | 777,750 | 427,763 | 777,750 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | BLECH ISAAC | Director | Option Exercise | C | 0.50 | 104 | 52 | 104 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | BLECH ISAAC | Director | Option Exercise | A | 0.55 | 16,875 | 9,281 | 16,875 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | BLECH ISAAC | Director | Option Exercise | A | 0.50 | 2 | 1 | 2 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.55 | 135,000 | 74,250 | 135,000 | |
| Apr 18 2018 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.50 | 18 | 9 | 18 | |
| Nov 27 2017 | MRNA | Marina Biotech, In ... | BLECH ISAAC | Director | Option Exercise | A | 1.80 | 473,457 | 852,223 | 473,457 | |
| Oct 24 2017 | MRNA | Marina Biotech, In ... | Weinstein Peter D. | Chief Legal Officer | Option Exercise | A | 2.40 | 60,000 | 144,000 | 60,000 | |
| Oct 06 2017 | MRNA | Marina Biotech, In ... | Shah Amit B. | Chief Financial Off ... | Option Exercise | A | 2.70 | 60,000 | 162,000 | 60,000 | |
| Jun 12 2017 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Buy | P | 0.39 | 10,000 | 3,900 | 11,127,141 | 11.1 M to 11.1 M (+0.09 %) |
| Jun 08 2017 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Buy | P | 0.38 | 2,500 | 950 | 11,097,141 | 11.1 M to 11.1 M (+0.02 %) |
| Jun 08 2017 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Buy | P | 0.39 | 20,000 | 7,800 | 11,117,141 | 11.1 M to 11.1 M (+0.18 %) |
| Apr 07 2017 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Chief Executive Off ... | Buy | P | 0.34 | 13,000 | 4,368 | 418,153 | 405.2 K to 418.2 K (+3.21 %) |
| Apr 07 2017 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Chief Executive Off ... | Buy | P | 0.43 | 22,500 | 9,563 | 440,653 | 418.2 K to 440.7 K (+5.38 %) |
| Apr 05 2017 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Chief Executive Off ... | Buy | P | 0.31 | 97,550 | 30,436 | 405,153 | 307.6 K to 405.2 K (+31.71 %) |
| Feb 14 2017 | MRNA | Marina Biotech, In ... | Hwang Larn | Chief Scientific Of ... | Option Exercise | A | 0.18 | 60,000 | 10,800 | 60,000 | |
| Feb 14 2017 | MRNA | Marina Biotech, In ... | Munsif Mihir | Chief Operating Off ... | Option Exercise | A | 0.18 | 60,000 | 10,800 | 60,000 | |
| Feb 08 2017 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Buy | P | 0.29 | 862,068 | 250,000 | 862,068 | 0 to 862.1 K |
| Feb 03 2017 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 307,603 | 207.6 K to 307.6 K (+48.17 %) |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Chief Executive Off ... | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Jan 04 2017 | MRNA | Marina Biotech, In ... | Calais Philippe | Director | Option Exercise | A | 0.17 | 81,000 | 13,770 | 81,000 | |
| Nov 22 2016 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Grant | A | 0.00 | 5,255,354 | 0 | 5,255,354 | 0 to 5.3 M |
| Nov 22 2016 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Grant | A | 0.00 | 23,123,558 | 0 | 23,123,558 | 0 to 23.1 M |
| Nov 22 2016 | MRNA | Marina Biotech, In ... | Trieu Vuong | Chairman of the Boa ... | Grant | A | 0.00 | 11,094,641 | 0 | 11,094,641 | 0 to 11.1 M |
| Nov 17 2016 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.10 | 35,000 | 3,500 | 35,000 | |
| Nov 17 2016 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Option Exercise | A | 0.10 | 35,000 | 3,500 | 35,000 | |
| Nov 17 2016 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.10 | 35,000 | 3,500 | 35,000 | |
| Nov 17 2016 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Interim CEO | Option Exercise | A | 0.10 | 35,000 | 3,500 | 35,000 | |
| Jan 05 2016 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.26 | 38,000 | 9,880 | 38,000 | |
| Jan 05 2016 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Director | Option Exercise | A | 0.26 | 38,000 | 9,880 | 38,000 | |
| Jan 05 2016 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.26 | 38,000 | 9,880 | 38,000 | |
| Jan 05 2016 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Option Exercise | A | 0.26 | 38,000 | 9,880 | 38,000 | |
| Jan 07 2015 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 0.64 | 38,000 | 24,130 | 38,000 | |
| Jan 07 2015 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Director | Option Exercise | A | 0.64 | 38,000 | 24,130 | 38,000 | |
| Jan 07 2015 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 0.64 | 38,000 | 24,130 | 38,000 | |
| Jan 07 2015 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Option Exercise | A | 0.64 | 38,000 | 24,130 | 38,000 | |
| Jan 02 2015 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Payment of Exercise | F | 0.33 | 309,055 | 101,988 | 822,283 | 1.1 M to 822.3 K (-27.32 %) |
| Sep 19 2014 | MRNA | Marina Biotech, In ... | Williams Donald Allen | Director | Option Exercise | A | 1.07 | 62,000 | 66,340 | 62,000 | |
| Sep 17 2014 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Option Exercise | A | 1.07 | 62,000 | 66,340 | 62,000 | |
| Sep 17 2014 | MRNA | Marina Biotech, In ... | Ranker Philip C | Director | Option Exercise | A | 1.07 | 62,000 | 66,340 | 62,000 | |
| Sep 17 2014 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Director | Option Exercise | A | 1.07 | 62,000 | 66,340 | 62,000 | |
| Sep 17 2014 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Option Exercise | A | 1.07 | 771,000 | 824,970 | 771,000 | |
| Apr 18 2014 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Director | Buy | P | 0.76 | 26,300 | 19,999 | 207,603 | 181.3 K to 207.6 K (+14.51 %) |
| Feb 10 2014 | MRNA | Marina Biotech, In ... | Pryor Cashman LLP | 10% Owner | Sell | S | 1.02 | 15,000 | 15,270 | 1,591,959 | 1.6 M to 1.6 M (-0.93 %) |
| Feb 10 2014 | MRNA | Marina Biotech, In ... | Pryor Cashman LLP | 10% Owner | Sell | S | 1.01 | 59,000 | 59,413 | 1,606,959 | 1.7 M to 1.6 M (-3.54 %) |
| Feb 10 2014 | MRNA | Marina Biotech, In ... | Pryor Cashman LLP | 10% Owner | Sell | S | 0.95 | 34,041 | 32,305 | 1,665,959 | 1.7 M to 1.7 M (-2.00 %) |
| Jan 06 2014 | MRNA | Marina Biotech, In ... | Ramelli Joseph W. | Director | Grant | A | 0.00 | 181,303 | 0 | 181,303 | 0 to 181.3 K |
| Jan 06 2014 | MRNA | Marina Biotech, In ... | Loren Stefan | Director | Grant | A | 0.00 | 181,303 | 0 | 181,303 | 0 to 181.3 K |
| Jan 06 2014 | MRNA | Marina Biotech, In ... | Ho Richard Theodore | Executive Vice Pres ... | Grant | A | 0.00 | 390,000 | 0 | 390,000 | 0 to 390 K |
| Jan 06 2014 | MRNA | Marina Biotech, In ... | Ranker Philip C | Former Interim CFO ... | Grant | A | 0.00 | 897,303 | 0 | 897,553 | 250 to 897.6 K (+358,921.20 %) |
| Jan 06 2014 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Grant | A | 0.00 | 1,131,000 | 0 | 1,132,338 | 1.3 K to 1.1 M (+84,529.15 %) |
| Oct 04 2013 | MRNA | Marina Biotech, In ... | Pryor Cashman LLP | 10% Owner | Sell | S | 0.24 | 35,000 | 8,334 | 1,700,000 | 1.7 M to 1.7 M (-2.02 %) |
| Oct 04 2013 | MRNA | Marina Biotech, In ... | Pryor Cashman LLP | 10% Owner | Sell | S | 0.25 | 65,000 | 16,335 | 1,735,000 | 1.8 M to 1.7 M (-3.61 %) |
| Sep 08 2011 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Acctg Offcer/ ... | Option Exercise | A | 0.22 | 25,000 | 5,500 | 25,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | Ho Richard Theodore | Executive V.P. R&D | Option Exercise | A | 0.21 | 300,000 | 63,000 | 300,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | Parker Peter | Director | Option Exercise | A | 0.21 | 75,000 | 15,750 | 75,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | Taylor Michael Douglas | Director | Option Exercise | A | 0.21 | 75,000 | 15,750 | 75,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | SESSLER GREGORY | Director | Option Exercise | A | 0.21 | 75,000 | 15,750 | 75,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | FLETCHER R JOHN | Director | Option Exercise | A | 0.21 | 75,000 | 15,750 | 75,000 | |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | POLISKY BARRY | Chief Scientific Of ... | Option Exercise | A | 0.20 | 115,000 | 23,000 | 115,000 | |
| Sep 07 2011 | MRNA | Marina Biotech, In ... | Karis James | Director | Option Exercise | A | 0.21 | 100,000 | 21,000 | 100,000 | |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 0.20 | 107,500 | 21,500 | 107,500 | |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Buy | J | 0.60 | 5,000 | 3,000 | 5,000 | 0 to 5 K |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Option Exercise | A | 0.20 | 435,000 | 87,000 | 435,000 | |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Buy | J | 0.60 | 5,000 | 3,000 | 8,375 | 3.4 K to 8.4 K (+148.15 %) |
| Aug 29 2011 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Buy | J | 4.76 | 875 | 4,165 | 3,375 | 2.5 K to 3.4 K (+35.00 %) |
| Aug 17 2011 | MRNA | Marina Biotech, In ... | Parker Peter | Director | Sell | J | 0.24 | 40,200 | 9,604 | 84,010 | 124.2 K to 84 K (-32.36 %) |
| Apr 15 2011 | MRNA | Marina Biotech, In ... | SESSLER GREGORY | Director | Option Exercise | A | 0.55 | 3,594 | 1,977 | 3,594 | |
| Apr 15 2011 | MRNA | Marina Biotech, In ... | Parker Peter | Director | Option Exercise | A | 0.55 | 3,594 | 1,977 | 3,594 | |
| Feb 15 2011 | MRNA | Marina Biotech, In ... | Parker Peter | Director | Buy | J | 0.00 | 116,253 | 0 | 124,210 | 8 K to 124.2 K (+1,461.02 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 3,780 | 4,574 | 2,495,065 | 2.5 M to 2.5 M (-0.15 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 2,056 | 2,467 | 2,498,845 | 2.5 M to 2.5 M (-0.08 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.19 | 10,730 | 12,769 | 2,500,901 | 2.5 M to 2.5 M (-0.43 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 16,784 | 19,805 | 2,511,631 | 2.5 M to 2.5 M (-0.66 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 19,550 | 22,874 | 2,528,415 | 2.5 M to 2.5 M (-0.77 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 10,700 | 12,412 | 2,547,965 | 2.6 M to 2.5 M (-0.42 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 1,900 | 2,185 | 2,558,665 | 2.6 M to 2.6 M (-0.07 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.14 | 1,300 | 1,482 | 2,560,565 | 2.6 M to 2.6 M (-0.05 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.13 | 2,600 | 2,938 | 2,561,865 | 2.6 M to 2.6 M (-0.10 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 1,200 | 1,344 | 2,564,465 | 2.6 M to 2.6 M (-0.05 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.11 | 1,800 | 1,998 | 2,565,665 | 2.6 M to 2.6 M (-0.07 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.10 | 400 | 440 | 2,567,465 | 2.6 M to 2.6 M (-0.02 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 700 | 763 | 2,567,865 | 2.6 M to 2.6 M (-0.03 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.08 | 1,000 | 1,080 | 2,568,565 | 2.6 M to 2.6 M (-0.04 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 700 | 840 | 2,569,565 | 2.6 M to 2.6 M (-0.03 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 400 | 472 | 2,570,265 | 2.6 M to 2.6 M (-0.02 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 670 | 784 | 2,570,665 | 2.6 M to 2.6 M (-0.03 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 1,530 | 1,775 | 2,571,335 | 2.6 M to 2.6 M (-0.06 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 19,200 | 22,080 | 2,572,865 | 2.6 M to 2.6 M (-0.74 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.14 | 9,005 | 10,266 | 2,592,065 | 2.6 M to 2.6 M (-0.35 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.13 | 5,100 | 5,763 | 2,601,070 | 2.6 M to 2.6 M (-0.20 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 15,100 | 16,912 | 2,606,170 | 2.6 M to 2.6 M (-0.58 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.12 | 600 | 669 | 2,621,270 | 2.6 M to 2.6 M (-0.02 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.11 | 26,200 | 29,082 | 2,621,870 | 2.6 M to 2.6 M (-0.99 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.10 | 12,000 | 13,200 | 2,648,070 | 2.7 M to 2.6 M (-0.45 %) |
| Jan 27 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 2,500 | 2,725 | 2,660,070 | 2.7 M to 2.7 M (-0.09 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.22 | 6,510 | 7,942 | 2,662,570 | 2.7 M to 2.7 M (-0.24 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 100 | 121 | 2,669,080 | 2.7 M to 2.7 M (0.00 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 23,800 | 28,798 | 2,669,180 | 2.7 M to 2.7 M (-0.88 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.21 | 600 | 723 | 2,692,980 | 2.7 M to 2.7 M (-0.02 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 400 | 481 | 2,693,580 | 2.7 M to 2.7 M (-0.01 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.20 | 17,907 | 21,488 | 2,693,980 | 2.7 M to 2.7 M (-0.66 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.19 | 3,883 | 4,621 | 2,711,887 | 2.7 M to 2.7 M (-0.14 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.18 | 14,200 | 16,756 | 2,715,770 | 2.7 M to 2.7 M (-0.52 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.17 | 3,000 | 3,510 | 2,729,970 | 2.7 M to 2.7 M (-0.11 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.16 | 2,100 | 2,436 | 2,732,970 | 2.7 M to 2.7 M (-0.08 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.15 | 300 | 345 | 2,735,070 | 2.7 M to 2.7 M (-0.01 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.30 | 200 | 260 | 2,735,370 | 2.7 M to 2.7 M (-0.01 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.29 | 300 | 387 | 2,735,570 | 2.7 M to 2.7 M (-0.01 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.28 | 900 | 1,152 | 2,735,870 | 2.7 M to 2.7 M (-0.03 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.27 | 5,935 | 7,537 | 2,736,770 | 2.7 M to 2.7 M (-0.22 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.26 | 22,865 | 28,810 | 2,742,705 | 2.8 M to 2.7 M (-0.83 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.25 | 34,200 | 42,750 | 2,765,570 | 2.8 M to 2.8 M (-1.22 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.24 | 4,900 | 6,076 | 2,799,770 | 2.8 M to 2.8 M (-0.17 %) |
| Jan 25 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.23 | 200 | 246 | 2,804,670 | 2.8 M to 2.8 M (-0.01 %) |
| Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.50 | 1,000 | 1,500 | 2,804,870 | 2.8 M to 2.8 M (-0.04 %) |
| Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.49 | 100 | 149 | 2,805,870 | 2.8 M to 2.8 M (0.00 %) |
| Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.46 | 4,500 | 6,570 | 2,805,970 | 2.8 M to 2.8 M (-0.16 %) |
| Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.45 | 100 | 145 | 2,810,470 | 2.8 M to 2.8 M (0.00 %) |